Related Experiment Video
Updated: Feb 15, 2026

Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement
Pierantonio Menna1, Emanuela Salvatorelli, Alessia Mattei
1Clinical Pharmacology Unit, University Hospital Campus Bio-Medico of Rome, Rome, Italy.
Abstract:
Colistin is a last resort antibiotic to treat multidrug-resistant Gram-negative bacteria infections. Colistin is administered intravenously in the form of its inactive prodrug colistin methanesulfonate (CMS). For patients with acute kidney impairment and continuous renal replacement therapy high extracorporeal clearance may cause a substantial removal of active colistin from the bloodstream, eventually decreasing its antibacterial efficacy. Currently recommended doses of CMS may therefore be inadequate for these patients. We report on the potential value of a modified regimen that adopts a loading dose of CMS (bolus of 9 MU vs. conventional 3 MU every 8 h), followed by maintenance (3 MU every 8 h). Preliminary pharmacokinetic evidence for the feasibility and efficacy of this regimen is described for 2 patients.
Insights
Colistin methanesulfonate (CMS) dosing may be insufficient for patients with kidney impairment undergoing continuous renal replacement therapy. A modified regimen with a higher loading dose shows potential for improved efficacy in treating multidrug-resistant infections.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Colistin is a critical antibiotic for treating multidrug-resistant Gram-negative bacterial infections.
- Colistin is administered as an inactive prodrug, colistin methanesulfonate (CMS).
- Patients with acute kidney impairment on continuous renal replacement therapy (CRRT) may experience significant extracorporeal clearance of active colistin, potentially reducing treatment effectiveness.
Purpose of the Study:
- To evaluate a modified CMS dosing regimen for patients with acute kidney impairment on CRRT.
- To assess the feasibility and efficacy of a higher loading dose of CMS in this patient population.
Main Methods:
- A modified dosing regimen was proposed: a loading dose of 9 MU (Milliunits) of CMS, followed by maintenance doses of 3 MU every 8 hours.
- Preliminary pharmacokinetic data were collected and analyzed for two patients receiving this modified regimen.
Main Results:
- The modified regimen involved a higher initial bolus of CMS compared to the conventional dose.
- Preliminary pharmacokinetic evidence suggests the feasibility and potential efficacy of the proposed modified CMS regimen in the studied patients.
Conclusions:
- Current CMS dosing may be inadequate for patients with acute kidney impairment undergoing CRRT.
- A modified regimen with an increased loading dose of CMS warrants further investigation for optimizing colistin therapy in critically ill patients with renal dysfunction.
More Related Videos
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...

